CICC Financial Trading discloses dealings in Yichang HEC shares
On June 25, 2025, CICC Financial Trading Limited disclosed dealings in the shares of YiChang HEC ChangJiang Pharmaceutical Co., Ltd., pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers. The transactions involved closing proprietary positions arising from unsolicited client-driven dealings. CICC Financial Trading purchased 685,600 shares for a total of USD9,599,807.5500, with the highest price paid being USD14.0021 per share. Simultaneously, CICC Financial Trading sold 685,600 shares, receiving USD9,614,276.0000, with the highest price received at USD14.1800 per share and the lowest at USD13.9200. These dealings were conducted on CICC Financial Trading's own account, as an exempt principal trader connected with the Offeror, and the company is ultimately owned by China International Capital Corporation Limited.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Yichang HEC ChangJiang Pharmaceutical publishes news
Free account required • Unsubscribe anytime